AzTrials
AzTrials

Human Olfactory AmygdalaNCT04699799

Characterization of Human Olfactory Amygdala Subregions

A study testing Present odors to participants while recording brain activity in people with Human Olfactory Amygdala, run by Northwestern University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Human Olfactory Amygdala
What is being tested?
Present odors to participants while recording brain activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
1 Jan 2022to 1 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • older than 18 years of age

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christina Zelano, PhD contact

312-503-4437

c-zelano@northwestern.edu

United States1 site, 1 recruiting
  • Northwestern human olfaction lab

    Chicago, Illinois, 60611

    Research Study Assistant, 3125034437

    Recruiting

Other trials in United States

About this study

We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb

Read the detailed description

Specific Aims:

The human amygdala is part of primary olfactory cortex, in that it receives direct monosynaptic input from the olfactory bulb1-4. This suggests an important role for the amygdala in olfactory processing, yet the anatomical and functional properties of olfactory inputs to the human amygdala are largely unexplored. The overarching goal of this proposal is to elucidate the role of amygdala subregions in human olfactory processing.

The olfactory bulb projects in parallel to multiple cortical areas, each of which is thought to play a unique role in olfactory processing5-10. Within the amygdala, several distinct subregions receive direct, monosynaptic bulb input, suggesting distinct roles, yet their olfactory functions are not fully understood. Rodent studies have begun to explore potential roles for these subregions in olfactory-guided social and approach/avoid behaviors11- 15, with the first-ever recordings of the posterolateral cortical amygdala accomplished recently16. However, our understanding of these areas is still incomplete. Notably, most rodent studies on the olfactory amygdala subregions have focused on the accessory olfactory system, which humans lack. Furthermore, most human studies have not considered olfactory amygdala subregions separately17-21. This is a critical consideration, both because the majority of amygdala subregions do not receive olfactory inputs and because those that do likely play distinct roles in olfactory processing. These roles cannot be understood without analyzing the subregions separately. Thus, there is a strong need for more research into the role of the human amygdala subregions in olfaction. Importantly, olfactory amygdala subregions have been implicated in SUDEP22-26, the leading cause of death in temporal lobe epilepsy. Understanding the anatomical and functional properties of these regions is therefore of clinical importance as well.

This research will study human olfactory amygdala subregions using a multi-faceted, rigorous approach. It will combine specialized high-resolution diffusion-weighted imaging, high-resolution amygdala-targeted fMRI, rare direct electrical stimulation of the human amygdala (purely clinically prescribed) and human psychophysics, each suited to address a different question.

Aim 1: To anatomically and functionally characterize the primary olfactory cortical regions of the human amygdala. Experiments for this aim will carefully characterize human primary olfactory amygdala subregions at the anatomical and functional levels. Experiment 1A will use specialized diffusion- weighted imaging to localize olfactory tracts projecting to and from amygdala subregions. Experiment 1B will use resting fMRI and k-means clustering algorithms to parcellate and characterize amygdala subregions based on distinct whole-brain functional connectivity profiles. Experiment 1C will use event-related fMRI to functionally localize odor-responsive subregions of the amygdala. The hypothesis is that the medial, cortical and periamygdaloid subregions of the amygdala will exhibit structural connectivity with the olfactory bulb, enhanced odor-responsiveness compared to other subregions, and distinct whole-brain functional connectivity profiles.

Aim 2: To test the hypothesis that activity in distinct amygdala subregions reflects distinct olfactory behaviors. Experiments for this aim will use fMRI-derived ensemble patterns and time-series to explore distinct olfactory roles for amygdala subregions, with excellent spatial resolution and simultaneous coverage of the entire amygdala. The use of fMRI ensemble patterns is ideal, since olfactory cortical areas including the amygdala use a distributive mode of coding16. Experiment 2A will use fMRI to measure activity across all amygdala subregions while presenting identical odors under different ecologically relevant contexts (social, spatial and food). Experiment 2B will use fMRI to examine correlations between amygdala fMRI patterns and olfactory approach/avoid behaviors. The hypothesis is that, as in rodents, activity in the medial amygdala will reflect olfactory-guided social perceptual decisions and that activity in the cortical amygdala will reflect olfactory-guided approach/avoid behaviors.

Aim 3: To assess the necessity of olfactory amygdala subregions in distinct olfactory behaviors. To assess the necessity of olfactory amygdala subregions in the distinct olfactory behaviors described above in Aim 2, Experiment 3 will use intracranial electrophysiology methods to record directly from, and deliver electrical stimulation directly into, human olfactory amygdala sub-regions during the olfactory tasks from Aim 2. Stimulation will not deviate from clinical protocols, and will be performed by clinicians only. This method provides direct recordings of neural activity, and allows disruption of neural activity to test the necessity of specific regions for particular behaviors. The hypothesis is that disruption of oscillatory activity in the cortical amygdala will disrupt olfactory approach/avoid behaviors, while disruption of oscillatory activity in the medial amygdala will disrupt olfactory social perceptual decisions.

Being tested
Present odors to participants while recording brain activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Present odors to participants while recording brain activityOther

    Present odors to participants while recording brain activity

Study groups in NCT04699799
Study groupRoleWhat they receive
record brain activity while smelling odorsExperimentalRecord brain activity while smelling odors
Receives: Other: Present odors to participants while recording brain activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Strength of olfactory input to amygdala subregions

    We will assess the quantity of input to each amygdala subregion from the olfactory tract

    Measured: 4 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2021
  2. Study start1 Jan 2022
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04699799
Sponsor's protocol ID
STU00201349
Status last verified
May 2026
First submitted
4 Jan 2021
Last updated
12 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All data will be made freely available on our lab website and/or GitHub page. All raw data will be available

Questions about this trial

What is this clinical trial studying?

A study testing Present odors to participants while recording brain activity in people with Human Olfactory Amygdala, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christina Zelano, PhD (312-503-4437, c-zelano@northwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Strength of olfactory input to amygdala subregions (time frame: 4 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in